NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 44 filers reported holding NEUBASE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 30 | -94.8% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 576 | -98.8% | 0.00% | – |
| Q2 2022 | $51,000 | -76.3% | 48,497 | -57.6% | 0.00% | – |
| Q1 2022 | $215,000 | +9.7% | 114,473 | +64.3% | 0.00% | – |
| Q4 2021 | $196,000 | +67.5% | 69,682 | +113.8% | 0.00% | – |
| Q3 2021 | $117,000 | -71.6% | 32,585 | -62.1% | 0.00% | – |
| Q2 2021 | $412,000 | +396.4% | 85,955 | +664.5% | 0.00% | – |
| Q1 2021 | $83,000 | +130.6% | 11,244 | +121.1% | 0.00% | – |
| Q4 2020 | $36,000 | +157.1% | 5,086 | +182.6% | 0.00% | – |
| Q3 2020 | $14,000 | -12.5% | 1,800 | 0.0% | 0.00% | – |
| Q2 2020 | $16,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,027,027 | $14,169,000 | 0.85% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 103,500 | $723,000 | 0.55% |
| Sio Capital Management, LLC | 293,699 | $2,053,000 | 0.42% |
| GSA CAPITAL PARTNERS LLP | 121,389 | $849,000 | 0.14% |
| Frontier Wealth Management LLC | 145,000 | $1,014,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $2,174,000 | 0.06% |
| Oak Grove Capital LLC | 19,175 | $134,000 | 0.04% |
| PREMIER ASSET MANAGEMENT LLC | 14,977 | $105,000 | 0.02% |
| Trexquant Investment LP | 15,479 | $108,000 | 0.01% |
| PILLAR PACIFIC CAPITAL MANAGEMENT LLC | 19,800 | $138,000 | 0.01% |